152 related articles for article (PubMed ID: 9163435)
1. Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH.
Nilius AM; Beyer JM; Flamm RK; Tanaka SK
J Clin Microbiol; 1997 Jun; 35(6):1311-5. PubMed ID: 9163435
[TBL] [Abstract][Full Text] [Related]
2. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
[TBL] [Abstract][Full Text] [Related]
3. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
[TBL] [Abstract][Full Text] [Related]
4. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
McLinn S; Williams D
Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
[TBL] [Abstract][Full Text] [Related]
5. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.
Jones RN; Biedenbach DJ; Erwin ME; Beach ML; Pfaller MA
J Clin Microbiol; 1999 Jun; 37(6):1999-2002. PubMed ID: 10325362
[TBL] [Abstract][Full Text] [Related]
6. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
Burgess DS; Hastings RW; Horan JL
Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Delmée M; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889
[TBL] [Abstract][Full Text] [Related]
8. Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997.
Hogan PA; Sheehan DJ
Antimicrob Agents Chemother; 1998 Dec; 42(12):3313-4. PubMed ID: 9835536
[TBL] [Abstract][Full Text] [Related]
9. Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.
Woods GL; Williams-Bouyer N; Wallace RJ; Brown-Elliott BA; Witebsky FG; Conville PS; Plaunt M; Hall G; Aralar P; Inderlied C
J Clin Microbiol; 2003 Feb; 41(2):627-31. PubMed ID: 12574258
[TBL] [Abstract][Full Text] [Related]
10. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
11. Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
Barry AL; Fernandes PB; Jorgensen JH; Thornsberry C; Hardy DJ; Jones RN
J Clin Microbiol; 1988 Nov; 26(11):2415-20. PubMed ID: 2976773
[TBL] [Abstract][Full Text] [Related]
12. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
Peric M; Bozdogan B; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Mar; 47(3):1017-22. PubMed ID: 12604536
[TBL] [Abstract][Full Text] [Related]
13. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
14. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
Bogdanovich T; Bozdogan B; Appelbaum PC
Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
Pontani D; Washton H; Bouchillon S; Johnson J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.
Jacobs MR; Bajaksouzian S; Zilles A; Lin G; Pankuch GA; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910
[TBL] [Abstract][Full Text] [Related]
17. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Berry V; Thorburn CE; Knott SJ; Woodnutt G
Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Fass RJ
Antimicrob Agents Chemother; 1993 Oct; 37(10):2080-6. PubMed ID: 8257127
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae.
Bergman KL; Olsen KM; Peddicord TE; Fey PD; Rupp ME
Antimicrob Agents Chemother; 1999 May; 43(5):1291-3. PubMed ID: 10223956
[TBL] [Abstract][Full Text] [Related]
20. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]